DekaBank Deutsche Girozentrale decreased its stake in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 18.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 423,412 shares of the company's stock after selling 95,000 shares during the quarter. DekaBank Deutsche Girozentrale owned approximately 0.84% of Enhabit worth $3,307,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Empowered Funds LLC raised its holdings in shares of Enhabit by 87.7% in the first quarter. Empowered Funds LLC now owns 147,594 shares of the company's stock valued at $1,719,000 after acquiring an additional 68,966 shares in the last quarter. WINTON GROUP Ltd purchased a new position in Enhabit during the 2nd quarter valued at about $955,000. Marshall Wace LLP bought a new stake in shares of Enhabit in the 2nd quarter valued at about $1,941,000. Orion Portfolio Solutions LLC lifted its position in shares of Enhabit by 72.5% in the 1st quarter. Orion Portfolio Solutions LLC now owns 96,833 shares of the company's stock worth $1,128,000 after purchasing an additional 40,684 shares during the period. Finally, AREX Capital Management LP boosted its stake in shares of Enhabit by 2.5% during the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company's stock valued at $22,056,000 after purchasing an additional 59,353 shares in the last quarter.
Enhabit Stock Up 5.2 %
Shares of NYSE EHAB traded up $0.36 during mid-day trading on Friday, reaching $7.25. 286,080 shares of the company were exchanged, compared to its average volume of 585,436. Enhabit, Inc. has a 1 year low of $6.85 and a 1 year high of $11.74. The firm has a 50-day moving average of $7.65 and a 200 day moving average of $8.66. The stock has a market cap of $364.53 million, a price-to-earnings ratio of -42.64 and a beta of 1.81. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.73.
Enhabit (NYSE:EHAB - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.02. The company had revenue of $260.60 million during the quarter, compared to analysts' expectations of $265.99 million. Enhabit had a negative net margin of 0.84% and a positive return on equity of 1.61%. During the same quarter in the prior year, the company posted $0.04 earnings per share. On average, research analysts expect that Enhabit, Inc. will post 0.26 earnings per share for the current year.
Insider Buying and Selling
In related news, Director Jeffrey Bolton acquired 5,000 shares of the company's stock in a transaction dated Thursday, August 22nd. The shares were purchased at an average cost of $8.01 per share, with a total value of $40,050.00. Following the completion of the acquisition, the director now directly owns 78,877 shares of the company's stock, valued at $631,804.77. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.90% of the stock is owned by company insiders.
Enhabit Profile
(
Free Report)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Recommended Stories
Before you consider Enhabit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.
While Enhabit currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.